{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":3,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":46,"n_cols":5,"rows_kept":46,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[11,2,11,3],[12,2,12,3],[14,2,14,3],[23,2,23,3],[23,4,23,5],[24,2,24,3],[24,4,24,5],[25,2,25,3],[25,4,25,5],[26,2,26,3],[27,2,27,3],[28,2,28,3],[29,2,29,3],[30,2,30,3],[31,2,31,3],[34,2,34,3],[34,4,34,5],[35,2,35,3],[35,4,35,5],[36,2,36,3],[36,4,36,5],[37,2,37,3],[38,2,38,3],[39,2,39,3],[40,2,40,3],[41,2,41,3],[42,2,42,3],[43,2,43,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910506394703321"]
[null,null,"Autore",null,"McCauley Jerry"]
[null,null,"Titolo",null,"Approaches to Chronic Kidney Disease : A Guide for Primary Care Providers and Non-Nephrologists"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer International Publishing AG, , 2021"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"3-030-83082-9"]
[null,null,"Descrizione fisica",null,"1 online resource (448 pages)"]
[null,null,"Soggetti",null,"Kidneys - Diseases"]
[{"$nulls":4},"Chronic diseases"]
[{"$nulls":4},"Kidney Diseases"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Preface -- Acknowledgments -- Contents -- Contributors -- Chapter 1: Renal Physiology for Primary Care Clinicians -- Introduction -- Vascular Structure of the Kidney -- Glomerular Filtration Rate (GFR) -- Renal Tubular Function -- Proximal Tubular Segments -- Loop of Henle -- Distal Tubular Segments -- Collecting Tubules -- References -- Chapter 2: State of the Care, Definition, and Epidemiology of Chronic Kidney Disease -- Definition of Chronic Kidney Disease -- Significance of Chronic Kidney Disease -- Economic Burden of Chronic Kidney Disease -- Common Causes of ESRD -- Epidemiology/Prevalence of Chronic Kidney Disease -- Risk Factors for CKD and CKD Prevalence -- Awareness of CKD -- Prevention and Screening -- Screening -- Slowing the Progression of CKD -- Summary -- References -- Chapter 3: Screening Tests for CKD Detection -- Introduction -- Urinalysis -- Urine Specimen Collection -- Gross Examination -- Urine Dipstick -- Urine Sediment -- Glomerular Filtration Rate and Its Assessment -- Assessment of GFR -- Measurement of GFR -- Estimation of GFR -- Creatinine as a Marker to Estimate GFR -- Creatinine Clearance -- Equations for Estimating GFR from Serum Creatinine -- Cockcroft-Gault Formula -- MDRD Study Equation -- CKD-EPI Equation -- Urea as a Marker for GFR -- Serum Cystatin C -- GFR Assessment in Circumstances Requiring High Degree of Accuracy -- Kidney Donor Evaluation -- Drug Dosing -- Assessing "]
[{"$nulls":4},"Kidney Function Beyond eGFR -- Disease Duration -- Major Causes and Classification of Kidney Disease -- Proteinuria -- Albuminuria -- Measurement of Total Urine Protein Excretion -- Approach to Patient with Proteinuria -- Hematuria -- Radiologic Assessment in Renal Disease -- Ultrasound -- Computed Tomography (CT) -- Magnetic Resonance Imaging -- Abdominal Radiography -- Renal Arteriography -- Radionuclide Studies."]
[{"$nulls":4},"Retrograde or Anterograde Pyelography -- Renal Biopsy -- Indications of Renal Biopsy -- Contraindications -- Pre-biopsy Work-Up -- Complications -- References -- Chapter 4: Slowing Chronic Kidney Disease Progression -- Introduction -- CKD Detection -- Slowing CKD Progression by Optimizing Hypertension Control -- Slowing CKD Progression by Reducing Proteinuria -- Slowing Diabetic Kidney Disease -- Slowing CKD Progression in Cardiovascular Disease -- Slowing CKD Progression by Optimizing Metabolic Acidosis -- Hyperlipidemia -- Hyperuricemia -- Obesity and CKD Progression -- Smoking -- New Therapies Targeting Renal Fibrosis to Slow CKD Progression -- Conclusion -- References -- Chapter 5: Progression of CKD and Uremic Symptoms -- Definition of Chronic Kidney Disease (CKD) -- Clinical Presentation -- Things to Include in Routine History and Physical in a Patient with CKD -- Making Use of Existing Laboratory Data and Imaging Studies -- CKD and Its Risk Factors -- Etiology of CKD -- Stages of CKD and Its Progression -- CKD and Its Progression -- Definition of CKD Progression and Its Assessment -- Disclosing to Patients -- Referral to a Nephrologist -- Natural History of Renal Disease -- Pathophysiology of CKD and Its Progression -- Factors to Predict the Progression of CKD -- Intraglomerular Hypertension and Glomerular Hypertrophy -- Proteinuria -- Tubulointerstitial Fibrosis -- Diabetes Mellitus and CKD -- Metabolic Acidosis -- Uric Acid -- Use of Smoking and Illicit Drugs -- Interaction with Healthcare Professionals -- Taking a Charge of Own Health -- Socioeconomic Impact -- APOL1 Genotype in African Americans (AA) -- CKD Manifestations and Their Management -- Uremia -- Pathogenesis of Uremia -- Signs and Symptoms of Uremia -- Approach to Management of Uremia -- Conclusion -- References -- Chapter 6: Diabetic Kidney Disease -- Introduction."]
[{"$nulls":4},"Pathogenesis -- Incidence and Prevalence -- Risk Factors -- Age -- Race/Ethnicity -- Obesity -- Uncontrolled Blood Sugar -- Hypertension -- Albuminuria -- Role of Kidney Biopsy -- Pathology -- Progression -- Treatment -- Following DKD Patient During Treatment to Control CV Risk Factors -- References -- Chapter 7: Hypertensive Kidney Disease -- Introduction and Epidemiology -- Definitions -- Epidemiology of Hypertensive Kidney Disease -- Causes of Hypertensive Kidney Disease -- Impaired Sodium Excretion -- Renin-Angiotensin-Aldosterone System -- Sympathetic Nervous System -- Impaired Renal Autoregulation in CKD -- Inflammation -- BP Target in Hypertensive Kidney Disease -- Blood Pressure Monitoring and Blood Pressure Patterns in Hypertensive Kidney Disease -- Masked Hypertension in CKD -- Resistant Hypertension in Hypertensive Kidney Disease -- Role of Hypertension in the Progression of CKD -- Treatment of Hypertensive Kidney Disease -- Use of RAAS Inhibition in CKD -- Diuretics -- Aldosterone Antagonists in Hypertensive Kidney Disease -- Dietary Potassium Supplementation -- SGLT-2 Inhibitors -- Allopurinol -- Aspirin and Clopidogrel -- Weight Loss for Treatment of Hypertensive Kidney Disease -- Evaluation for Renal Artery Stenosis in Hypertensive Kidney Disease -- Hypertensive Emergency in Hypertensive Kidney Disease -- Prognosis -- References -- Chapter 8: Infection-Related Kidney Disease -- Introduction -- Virus-Induced "]
[{"$nulls":4},"Kidney Disease -- Human Immunodeficiency Virus (HIV) -- Human Immunodeficiency Virus-Associated Nephropathy (HIVAN) -- APOL1 Gene -- HIV-Associated Immune Complex Kidney Disease (HIVICK) -- Treatment of HIV with HIV-Associated Anti-Retro-Viral Therapy (HAART) -- Protease Inhibitors (PI) -- Nucleotide Reverse Transcriptase Inhibitors (NRTI) -- Non-nucleotide Reverse Transcriptase Inhibitors (NNRTI) -- Hepatitis C Virus (HCV)."]
[{"$nulls":4},"HCV Treatment -- Hepatitis B Virus -- HBV Treatment -- Hepatitis E Virus -- Other Virus-Associated Renal Disease -- Flaviviruses -- Dengue Virus -- Hantavirus -- Coronavirus-19 -- Bacterial Infections -- Post-streptococcal Glomerulonephritis -- Infection-Related Glomerulonephritis -- Mycobacterial Infections -- Fungal Infections -- Protozoan and Parasitic Infections -- Malaria -- Leptospirosis -- Leishmaniasis -- Schistosomiasis -- Filariasis -- Conclusion -- References -- Chapter 9: Hepatorenal Syndrome -- Epidemiology -- Pathophysiology of HRS -- HRS-AKI -- HRS-NAKI -- Clinical Manifestations -- Diagnosis -- Differential Diagnosis -- Treatment -- Medical Management -- TIPS -- Renal Replacement Therapy -- Liver Transplantation -- Prevention -- Prognosis -- References -- Chapter 10: Lupus Nephritis -- Introduction -- Pathophysiology -- Diagnosis -- Treatment -- Clinical Response Definitions -- Treatment Protocols (Please See Table 10.1 for a Summary) -- Induction Therapy -- Maintenance Therapy -- Emerging Therapies and Protocols -- Antimalarials in LN -- B-cell Depletion -- Management of Class V LN -- Pregnancy and LN -- Dialysis and Transplantation in LN -- Conclusion -- References -- Chapter 11: Onconephrology -- Introduction -- Assessment of Kidney Function in Cancer Patients -- Acute Kidney Injury in Cancer Patients -- Tumor Lysis Syndrome -- Therapy-Related Acute Kidney Injury -- Traditional Chemotherapeutic Agents -- Platinum Salts -- Methotrexate and Pemetrexed -- Ifosfamide and Cyclophosphamide -- Nitrosoureas -- Gemcitabine and Mitomycin C -- Targeted Therapy -- Vascular Endothelial Growth Factor (VEGF) Inhibitors -- BRAF Inhibitors -- Anaplastic Lymphoma Kinase (ALK) Inhibitors -- Proteasome Inhibitors -- Immunotherapy -- Immune Checkpoint Inhibitors (ICPI) -- Chimeric Antigen Receptor T-Cell (CAR-T) Therapy -- Radiation Nephropathy."]
[{"$nulls":4},"Hematopoietic Stem Cell Transplantation (HSCT) -- Cancer-Related Kidney Disease -- Paraprotein-Related Kidney Disease -- Classification of Paraprotein-Related Diseases -- Clinical and Histological Manifestations of Renal Involvement in Plasma Cell Dyscrasias -- Multiple Myeloma -- Evaluation of Suspected Monoclonal Gammopathy -- Treatment of Monoclonal Gammopathies with Renal Involvement -- Leukemia and Lymphoma -- Paraneoplastic Glomerular Disease -- Urinary Tract Obstruction -- Renal Cell Carcinoma -- CKD, ESRD, and Cancer -- References -- Chapter 12: Complications of Chronic Kidney Disease: Electrolyte and Acid-Base Disorders -- Acidemia of Chronic Kidney Disease -- Epidemiology -- Pathophysiology -- Clinical Findings -- Adverse Effects -- Treatment -- Available Therapeutics -- Calculation of Bicarbonate Deficit -- Dietary Management of Metabolic Acidosis of Chronic Kidney Disease -- Pharmaceutical Management -- Sodium Disorder and Chronic Kidney Disease -- Epidemiology -- Pathophysiology of Concentrating and Diluting Defects in Chronic Kidney Disease -- The Counter-Current Mechanism in Chronic Kidney Disease -- Clinical Implications -- Treatment -- Hypovolemic Hyponatremia Secondary to Volume Deficits -- Euvolemic/Hypervolemic Hyponatremia -- ADH Inhibitors -- Water Restriction -- Use of Loop Diuretics -- Hypernatremia and Chronic Kidney Disease -- Hyponatremia and End-Stage Renal Disease -- "]
[{"$nulls":4},"Potassium and Chronic Kidney Disease -- Epidemiology -- Hyperkalemia in Chronic Kidney Disease -- Mechanism of Hyperkalemia and Chronic Kidney Disease -- Clinical Sequel -- Treatment -- Sodium Polystyrene Sulfonate -- Calcium Polystyrene Sulfonate -- Patiromer -- Sodium Zirconium Cyclosilicate -- Renal Replacement Therapy -- Hypokalemia in Chronic Kidney Disease -- Clinical Sequel -- Goals of Treatment -- Potassium Preparation -- References."]
[{"$nulls":4},"Chapter 13: Anemia in Chronic Kidney Disease."]
[null,"2.","Record Nr.",null,"UNINA9910375809103321"]
[null,null,"Autore",null,"Di Cosmo Roberto"]
[null,null,"Titolo",null,"Proceedings of the 1st International Workshop on Open Component Ecosystems"]
[null,null,"Pubbl/distr/stampa",null,"[Place of publication not identified], : Association for Computing Machinery, 2009"]
[null,null,"Descrizione fisica",null,"1 online resource (58 p.;)"]
[null,null,"Collana",null,"ACM Conferences"]
[null,null,"Soggetti",null,"Information Technology - Computer Science (Hardware & Networks)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,"3.","Record Nr.",null,"UNINA9910346779503321"]
[null,null,"Autore",null,"Reinke Thomas"]
[null,null,"Titolo",null,"Tragverhalten von biegebeanspruchten Stahlmasten mit polygonalen Querschnitten"]
[null,null,"Pubbl/distr/stampa",null,"KIT Scientific Publishing, 2015"]
[null,null,"ISBN",null,"1000047608"]
[null,null,"Descrizione fisica",null,"1 online resource (getr. Zählung p.)"]
[null,null,"Collana",null,"Berichte zum Stahl- und Leichtbau / Karlsruher Institut für Technologie, Versuchsanstalt für Stahl, Holz und Steine, Stahl- und Leichtbau"]
[null,null,"Soggetti",null,"Technology: general issues"]
[null,null,"Lingua di pubblicazione",null,"Tedesco"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","This work deals with the bending moment capacity of thin-walled steel poles with polygonal sections. Based on experimental and numerical investigations the bearing behavior of steel poles in bending with polygonal sections with an arbitrary number of corners up to the transition from a polygonal section to a round section is presented. Thereby the bearing behavior as a shell and the influence of imperfections are considered."]